"Notre établissement public de santé propose des consultations médicales spécialisées dans différents domaines. La direction, les médecins et l'ensemble des professionnels mettent tout en œuvre pour vous faire bénéficier de soins de qualité et des meilleurs services possibles. Le Centre Hospitalier de Cholet est certifié pour la 4ème fois par la HAS, depuis novembre 2016. Le laboratoire de biologie médicale est accrédité pour la qualité de ses prestations. Pour connaître le numéro du service que vous recherchez, cliquez sur toutes nos coordonnées ou bien rendez-vous sur notre site internet."

During the past decade, Centre Hospitalier de Cholet conducted 73 clinical trials. In the 10-year time frame, 73 clinical trials started and 4 clinical trials were completed, i.e. on average, 5.5% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 4 clinical trials were completed. i.e. 10.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier de Cholet" #1 sponsor was "Nantes University Hospital" with 10 trials, followed by "University Hospital, Angers" with 9 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 8 trials sponsored, "ARCAGY/ GINECO GROUP" with 6 trials sponsored and "Centre Hospitalier Departemental Vendee" with 6 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de Cholet" #1 collaborator was "AstraZeneca" with 4 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 2 trials as a collaborator, "Centre Hospitalier de Cholet" with 2 trials as a collaborator and "Centre Hospitalier le Mans" with 2 trials as a collaborator. Other collaborators include 105 different institutions and companies that were collaborators in the rest 109 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de Cholet" are "Colorectal Cancer" (4 trials), "Ovarian Cancer" (4 trials), "Metastatic Breast Cancer" (3 trials), "Rheumatoid Arthritis" (3 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Centre Hospitalier de Cholet" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de Cholet" are "Drug" (44 trials), "Other" (25 trials), "Procedure" (5 trials), "Biological" (3 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (4 trials), "Placebo" (4 trials), "Durvalumab" (3 trials), "Paclitaxel" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de Cholet" are 75 trials for "All" genders and 19 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Hospitalier de Cholet". undefined are not yet recruiting, 34 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Centre Hospitalier de Cholet, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de Cholet, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 26 trials that are defined as “Not Applicable".

Centre Hospitalier de Cholet has several departments that took part in Clinical trials: "Hôpital de Cholet - Pneumologie" - 5 trials, "CH de Cholet; oncologie" - 2 trials, "Centre Hospitalier de Cholet Service d'Hépato-Gastro-Entérologie" - 2 trials